anxiety – Page 3 – mycolab.ai

Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence

mycolabadmin

Psychedelic drugs like LSD and psilocybin enhance creativity by disrupting the brain’s Default Mode Network, allowing people to break free from rigid thinking patterns. This paper proposes that artificial intelligence systems could be designed to mimic these same cognitive effects—introducing novel information, making unexpected connections, and gradually expanding comfort with new ideas—thereby enhancing human creativity without drugs. By personalizing AI systems to each person’s personality type and gradually increasing novelty levels, these tools could make creative thinking accessible to people who might not naturally gravitate toward it.

An Occupational Perspective on Psychedelic Therapy: A Scoping Review

mycolabadmin

This review examines how psychedelic therapy affects people’s daily lives and overall health from an occupational therapy perspective. Using interviews from nine studies, researchers found that people using psychedelics for mental health reported becoming more mindful and engaged in meaningful activities, better understanding themselves, increased motivation for positive change, and stronger connections with others and nature. The findings suggest psychedelic-assisted therapy can be understood as a meaningful occupation that enhances participation in everyday life rather than a harmful activity.

Dissecting the difference between positive and negative brain health sentiment using X data

mycolabadmin

This study examined over 390,000 posts on X (formerly Twitter) about brain and health to understand how people express positive and negative feelings. Researchers found that negative posts were shared more often and were linked to serious health concerns like COVID-19 and brain inflammation. People expressing negative sentiment mentioned medications like lorazepam and comfort foods like pizza, while those with positive sentiment discussed resilience, mindfulness, and different medications. The research highlights both the benefits and dangers of sharing health information on social media.

Virtual reality and psychedelics: new perspectives and new possibilities in the treatment of alcohol use disorder

mycolabadmin

This article discusses how virtual reality technology that simulates psychedelic experiences could improve treatment for alcohol addiction. Virtual reality simulations can mimic the brain effects of psychedelics like psilocybin, and could help prepare patients for treatment, extend its benefits, or even work as a standalone therapy. This innovation could make psychedelic-assisted therapy more accessible and easier to standardize across different treatment centers.

Simultaneous cannabis and psychedelic use among festival and concert attendees in Colorado: characterizing enhancement and adverse reactions using mixed methods

mycolabadmin

This study surveyed music festival and concert attendees in Colorado about their experiences using cannabis and psychedelics together. Researchers found that most people reported cannabis made their psychedelic experience better by reducing anxiety, enhancing mood, or intensifying effects. Only a small percentage experienced negative effects like increased anxiety or confusion. The study suggests cannabis may help people manage difficult psychedelic trips, though more research is needed to understand how different types and amounts of cannabis affect outcomes.

A systematic review to assess the use of psilocybin in the treatment of headaches

mycolabadmin

Researchers reviewed eight studies examining whether psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, could treat various types of headaches and migraines. Most studies found that psilocybin provided clinically significant relief, with participants experiencing improvements in how often they got headaches, how intense they were, and how long they lasted. However, some users experienced side effects like hallucinations or temporary increases in anxiety, and the compound remains illegal in most countries, limiting current research.

Psychedelic use in Poland: prevalence, correlates and social attitudes

mycolabadmin

This study found that about 6% of Polish adults have tried psychedelic drugs like LSD or magic mushrooms, mostly young men in cities driven by curiosity. Most users took these substances at home and described mixed experiences. While negative attitudes toward psychedelics were common overall, people with meditation experience and previous psychedelic use had more positive views about their therapeutic potential.

Factors governing consumers buying behavior concerning nutraceutical product

mycolabadmin

This study examines why people buy nutraceutical products like health supplements and functional foods. Key factors include knowing the health benefits, product taste and packaging, affordability and availability, and recommendations from healthcare professionals. The study found that age, education, and gender affect purchasing decisions, and online shopping has become increasingly important. Companies should focus on innovative products with simple health messages to better serve different consumer groups.

Biological studies of clavine alkaloids targeting CNS receptors

mycolabadmin

This paper reviews clavine alkaloids, a class of natural compounds from ergot fungi that show promise as psychiatric medications. Unlike well-known psychedelics like LSD, clavine alkaloids may provide therapeutic benefits for anxiety and depression without strong hallucinogenic effects. The authors highlight how these compounds interact with brain receptors in ways that could make them safer and more effective medications for treating mood and neurological disorders.

Psychotomimetic compensation versus sensitization

mycolabadmin

This paper proposes a new way to understand why drugs that can cause psychosis-like effects (such as psilocybin, LSD, and ketamine) can also help treat depression and anxiety. The authors suggest that these drugs trigger compensatory responses in the brain that temporarily help us cope with stress, similar to how a runner’s high feels good during exercise. However, if someone uses these drugs repeatedly or experiences chronic stress, they may become sensitized and more vulnerable to developing actual psychotic symptoms over time.

Disease: anxiety